UroGen Pharma Ltd. Made Headway

Thu, Jun 13, 2024 at 07:18 PM
UroGen Pharma Ltd. Made Headway

UroGen Pharma Ltd. (URGN:NASDAQ) rocketted at $17.5, a gain of 37.6%. On Thu, Jun 13, 2024, URGN:NASDAQ touched a New 2-Week High of $17.5. The stock got featured on our News Catalysts scanner on Thu, Jun 13, 2024 at 01:45 PM in the 'BIOTECH' category. From Thu, May 30, 2024, the stock recorded 40.00% Up Days and 45.45% Green Days

About UroGen Pharma Ltd. (URGN:NASDAQ)

UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.